On Ozempic, Wegovy or Mounjaro, most of the weight lost is fat. But some comes from lean mass, around one quarter with tirzepatide in the SURMOUNT-1 trial, and that is where the difference between losing weight and losing strength comes into play.
The scale never tells you which tissue is disappearing. Two narratives clash: “GLP-1 medications melt your muscles” on one side, “it’s just fat” on the other. Both are wrong. Lean mass loss accompanies almost any substantial weight loss, with or without medication. The real question is whether it becomes disproportionate, whether your strength drops, and what you do to limit it.
This guide gives you the real trial figures, followed by seven practical rules: protein, strength training, rate of weight loss and strength monitoring.
Ozempic, Wegovy and Mounjaro: three names but two mechanisms
Ozempic and Wegovy both contain semaglutide. Semaglutide is a GLP-1 receptor agonist. It mimics some of the effects of glucagon-like peptide-1, a gut hormone released after meals.
Ozempic is indicated for the treatment of inadequately controlled type 2 diabetes. Wegovy uses the same molecule for medical weight management in certain people with obesity or overweight associated with complications.
Mounjaro contains tirzepatide. Tirzepatide activates both GLP-1 and GIP receptors. It is therefore more precisely described as a dual GIP and GLP-1 agonist.
These medications increase satiety, reduce appetite, slow gastric emptying to varying degrees and improve blood glucose regulation. Their main effect on weight does not involve directly burning muscle or fat.
They change hunger signals and make it easier to reduce energy intake, sometimes substantially.
In France, medications indicated for obesity remain prescription-only treatments. The ANSM emphasizes that they are part of an approach involving nutritional care and physical activity, and that they must not be used for purely cosmetic weight loss.
To understand the physiological pathways that can naturally increase satiety, see our analysis of foods that stimulate natural GLP-1 production · FR.
Why weight loss almost always leads to lean mass loss
Your body never draws all the missing energy from fat cells. During a calorie deficit, it mobilizes triglycerides stored in fat tissue, but it also reduces glycogen, the water associated with glycogen and sometimes body proteins.
Skeletal muscle is in a constant balance between two processes. Muscle protein synthesis builds or repairs contractile proteins. Muscle protein breakdown releases amino acids when the body needs them.
When energy intake drops sharply, several anabolic signals become weaker. Amino acid availability falls, post-meal insulin decreases and the mTORC1 pathway receives less stimulation. If resistance training disappears at the same time, muscle no longer receives enough mechanical stimulus to be maintained.
The body then becomes economically rational. It eliminates some tissue that is costly to maintain and underused. GLP-1 medications can indirectly intensify this situation.
Someone previously able to eat three full meals may find themselves full after a few bites. Protein-rich foods are sometimes the first to go because they are very filling and require more chewing.
Nausea, constipation, reflux or food aversion can further reduce intake. So the problem is not necessarily direct muscle toxicity. It is often the combination of a severe energy deficit, insufficient protein intake and a lack of mechanical tension.
How much muscle do you really lose on GLP-1 medications?
The data must be interpreted carefully.
What semaglutide shows
In the STEP 1 body composition substudy, participants receiving semaglutide at the dose used for obesity lost more fat than lean mass. After 68 weeks, total fat mass had decreased by around 19% and visceral fat by around 27%. Lean mass had decreased by around 10%.
Yet the relative proportion of lean mass in the body had increased. This paradox is easy to understand. Someone can lose lean mass in absolute terms while having a higher percentage of lean mass in their body if they lose even more fat.
What tirzepatide shows
In the SURMOUNT-1 DXA substudy, around 75% of the weight lost on tirzepatide came from fat mass and around 25% from lean mass. This distribution was similar to that observed in the placebo group losing weight through lifestyle and dietary interventions.
Another MRI analysis observed a reduction in thigh muscle volume, but also a decrease in fat infiltrating the muscle. A slightly smaller muscle with less fat infiltration does not necessarily have poorer function.
Lean mass does not mean muscle mass
DXA primarily separates three compartments:
- Fat mass
- Bone mineral content
- Non-bone lean mass
Lean mass includes muscles, but also water, glycogen, skin, organs and connective tissue. A rapid reduction in carbohydrates and calories reduces muscle glycogen. Each gram of glycogen is associated with several grams of water.
Some of the initial drop in lean mass may therefore reflect a change in body water rather than an equivalent loss of contractile proteins. This is why strength, walking speed and physical function are just as important as body composition measurements.
Muscle loss in the face or abdomen: what really happens
The Ozempic face phenomenon
The term “Ozempic face” is not a medical diagnosis. It describes a face that has become more hollow after substantial or rapid weight loss.
The face contains several fat compartments that support the cheeks, temples and area around the mouth. When their volume decreases, skin can look looser and bone structures can become more visible.
Skin aging, sun exposure, genetics and the rate of weight loss strongly influence this effect. There is no evidence that semaglutide specifically targets facial muscles.
The phenomenon is mainly a visible consequence of subcutaneous fat loss.
Loss around the abdomen
GLP-1 treatments often substantially reduce abdominal and visceral fat. This change is generally metabolically favorable, because excess visceral fat is associated with insulin resistance, inflammation and cardiovascular risk.
However, the abdominal muscles can lose volume like other muscles if protein intake is low and no resistance is applied to them. You cannot ask your body to lose only belly fat while automatically preserving every gram of local muscle tissue.
Our guide to losing belly fat after 40 · FR details the metabolic mechanisms that determine this change.
The 7 rules for protecting your muscles on GLP-1 medications
1. Measure strength instead of just watching the scale
Weight is not enough. Before starting treatment, establish a simple baseline with your healthcare professional or a qualified coach. You can track:
- Grip strength
- Number of chair stands
- Load used for squats or leg presses
- Load used for rows
- Walking speed
- Waist circumference
- Body weight
Repeat the same tests every four to eight weeks. Weight loss accompanied by stable strength is generally more reassuring than rapid weight loss accompanied by a continuous decline in performance.
A bioimpedance scale can track a trend, but its readings vary with hydration, salt, carbohydrates and measurement time. Our analysis of bioimpedance scales and their cellular measurements explains their main limitations.
2. Get enough protein every day
Protein provides the amino acids needed for muscle synthesis.
Leucine notably acts as a signal in mTORC1 activation. But leucine alone is not enough. Muscle needs all the essential amino acids to build new proteins.
A practical target is often between 1.2 and 1.6 grams of protein per kilogram of reference body weight per day. Reference body weight is often more relevant than current weight for someone with severe obesity.
This target must be personalized in cases of kidney disease, liver disease, frailty or a complex medical situation. To adjust the amount precisely, use our guide to how much protein to consume each day.
3. Spread protein across several meals
Eating all your daily protein at dinner is not ideal when portions have become very small. Aim for three opportunities to eat protein spread throughout the day. Each meal can contain around 25 to 40 grams of high-quality protein, depending on your size, age and digestive tolerance.
When your appetite is very low, start the meal with the protein source. A practical order:
- Protein
- Vegetables
- Starchy foods
- Added fats
High-protein yogurts, eggs, fish, lean meats, tofu, tempeh and protein powders can make it easier to reach your target with a limited volume of food. Our analysis of the maximum amount of protein you can use per meal · FR helps explain why absorption and muscle stimulation are not the same thing.
4. Strength train two to four times a week
Mechanical tension is the strongest signal telling the body that muscle is still needed. Two full-body sessions per week are a realistic minimum for a beginner. Every major muscle group should be stimulated regularly.
A simple structure:
- Squat or leg press
- Hip hinge
- Horizontal push
- Horizontal pull
- Vertical push
- Vertical pull
- Carry or core stability exercise
Perform two to four sets per exercise in a range of six to fifteen repetitions. Finish most sets with one to three repetitions still in reserve. The goal is not to burn as many calories as possible. It is to maintain or gradually increase strength.
5. Avoid unnecessarily accelerating weight loss
Almost complete appetite suppression may seem ideal, but it increases the likelihood of insufficient protein, micronutrient and energy intake. Extremely rapid weight loss is not always better weight loss.
Signs that should prompt you to contact your prescriber again include:
- Inability to finish small meals
- Repeated vomiting
- Dehydration
- Debilitating fatigue
- Continuous decline in strength
- Frequent dizziness
- Prolonged, very rapid weight loss
Never change the dose or injection frequency yourself. The goal of treatment is a lasting improvement in health, not the elimination of all hunger.
6. Protect everyday movement
Reduced energy intake can spontaneously decrease physical activity. You walk less. You sit for longer. You avoid stairs. These changes can happen without you realizing it.
This drop in everyday movement reduces energy expenditure, but it also removes thousands of small muscle contractions. Set a minimum activity level suited to your condition. A daily walk, active breaks and two to four strength sessions provide a more effective foundation than piling on exhausting cardio.
Muscle is preserved when it is used.
7. Plan for maintenance from the first month
Muscle protection should not start when you reach your target weight. It should be built in from the beginning of treatment.
Substantial weight regain was observed after stopping semaglutide in the STEP 1 extension. The risk is then regaining mainly fat if muscle decreased during the weight-loss phase.
This sequence can lead to a less favorable body composition despite a final weight close to the starting point. Your maintenance protocol should therefore include:
- Regular strength training
- Consistent protein intake
- Enough sleep
- Weight and waist circumference monitoring
- A long-term medical strategy
Exercise combined with GLP-1 agonist treatment showed better maintenance outcomes than medication or exercise alone in a trial involving liraglutide.
The weekly muscle protocol for GLP-1 treatment
Here is a minimal structure to adapt with your doctor and exercise professional.
Monday
Full-body strength training for 45 minutes
Tuesday
Brisk walking for 30 minutes
Wednesday
Active recovery and mobility for 20 minutes
Thursday
Full-body strength training for 45 minutes
Friday
Walking or moderate cardio for 30 minutes
Saturday
An activity of your choice that engages your muscles
Sunday
Rest and prepare protein-rich meals. Add a third strength training session when your recovery, fitness level and diet allow it. For people over 40, our protocol for preventing muscle loss and sarcopenia · FR complements this strategy.
Who is at the highest risk of muscle loss?
Not everyone receiving treatment faces the same risk. Closer monitoring is appropriate for people with several risk factors:
- Advanced age
- Pre-existing sarcopenia
- Low grip strength
- Very low protein intake
- Highly sedentary lifestyle
- Very rapid weight loss
- Persistent nausea or vomiting
- Chronic illness
- History of falls
- Repeated cycles of weight loss and regain
In a young, active, well-nourished person, a moderate decrease in lean mass does not mean the same thing as it does in an already frail 75-year-old. Functional context should always guide interpretation.
Are GLP-1 drugs dangerous for muscles?
The right answer is neither yes nor no. These drugs can create conditions that favor muscle loss because they sharply reduce energy intake.
But they can also improve mobility, decrease metabolic inflammation, reduce fat infiltration in muscles, and help people previously limited by their weight become active again.
A recent prospective study of semaglutide even observed improved grip strength despite an initial decrease in lean mass. So the danger does not lie in an isolated percentage on a DXA scan.
It emerges when several factors converge:
- Declining lean mass
- Declining strength
- Declining mobility
- Insufficient protein intake
- No resistance training
- Uncontrolled weight loss
Monitoring must cover both the tissue and its function.
The Verdict
GLP-1 treatments can transform obesity and diabetes management. They do not remove the need to protect your muscles, and the strongest strategy rests on three pillars: enough protein, progressive resistance training, and strength monitoring.
